MedX Holdings Inc (MEDH)

[hitpaydirt]

Kathy Roberton serves as the CEO & Director for MedX Holdings. MEDH is a Wyoming corporation which functions as a holding company with one wholly-owned subsidiary MedX Pharmaceuticals, Inc. an Alabama corporation. MEDH together with MedX Pharmaceuticals has a Three Prong Approach to be rolled out in Three Phases. Phase One: MedX Pharmaceuticals is licensed as a Manufacture/Re-Packager/Wholesale Distributor of Pharmaceuticals in the state of Alabama. Our first product is a 5% Lidocaine Ointment (Pain) that has an approved ANDA (Abbreviated New Drug Application) and next, 1.5% Diclofenac Ointment, both having over 125 million scripts written per year. MedX will advance to be licensed in up to 49 other states within the next 12 months. MedX has structured agreements with Amneal Pharmaceuticals and Gemini Laboratories who are the FDA Approved Manufactures of Finished Dosed Drugs. Phase Two: We have 3 products to launch in the OTC realm, two we will manufacture and one we will have a licensing agreement on. This may prove to be our largest sector as a couple products are suited for Kathleen Roberton’s contacts who own very large network marketing companies.